1.
Aladhab RA. Association of empagliflozin treatment with changes in the metabolic score for insulin resistance in Iraqi adults with type 2 diabetes: a 6-month prospective cohort study. Int J Basic Clin Pharmacol [Internet]. 2026 Aug. 5 [cited 2026 Aug. 6];. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/6451